Clinical trial
Development of Urinary-based Assay to Determine Treatment Coverage With Albendazole in Mass Drug Administration Programs
NCT04041427 is registered in ClinicalTrials.gov with Universidad Nacional de Salta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Urinary-based Assay to Determine Treatment Coverage With Albendazole in Mass Drug Administration Programs
- Lead sponsor
- Universidad Nacional de Salta
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 17, 2019
- Completion date
- February 28, 2020
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.